Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Clinical Trial in China

作者
Wenxiong Xu,Hong-liang He,Shun-wen Pan,Yuanli Chen,Mei-ling Zhang,Shu Zhu,Zhiliang Gao,Liang Peng,Jianguo Li
出处
期刊:Stem Cells International [Hindawi Publishing Corporation]
卷期号:2019: 1-10 被引量:73
标识
DOI:10.1155/2019/4130757
摘要

Background. Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a common type of liver failure with a high mortality. This study aimed at investigating the safety and efficacy of the combination treatment of plasma exchange (PE) and umbilical cord-derived mesenchymal stem cell (UC-MSCs) transplantation for HBV-ACLF patients.Methods. A total of 110 HBV-ACLF patients treated in our hospital from January 2012 to September 2017 were enrolled into this trial and divided into the control group ( n=30 ), UC-MSC group ( n=30 ), PE group ( n=30 ), and UC-MSC + PE group ( n=20 ) based on their treatments. The hepatic function, coagulation, and virological and immunological markers were assessed at baseline and 30, 60, 90, 180, and 360 days. The endpoint outcomes were death and unfavorable outcome (need for liver transplantation or death).Results. The UC-MSC + PE group had the lowest rates of death and unfavorable outcome at 30 days, 60 days, and 90 days posttreatment among the four groups, but the difference did not reach significances. The multivariate logistic regression analysis demonstrated that hemoglobin, prothrombin activity, and MELD (model for end-stage liver disease) score were the independent factors associated with the unfavorable outcome (all P<0.05 ). The levels of total bilirubin, alanine aminotransferase, aspartate transaminase, and MELD score were significantly decreased during treatments (all P<0.05 ).Conclusion. UC-MSCs combined with PE treatment had good safety but cannot significantly improve the short-term prognosis of HBV-ACLF patients with as compared with the single treatment. The long-term efficacy should be further evaluated. This trial is registered with registration no. NCT01724398 .

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Bruce完成签到,获得积分10
刚刚
科研小白发布了新的文献求助10
1秒前
Maestro_S的应助被狂野的舞仙采纳,获得10
1秒前
爱学术的LaoD完成签到,获得积分10
2秒前
罗钦完成签到,获得积分20
2秒前
2秒前
3秒前
3秒前
5秒前
5秒前
Gser发布了新的文献求助10
5秒前
6秒前
Flong发布了新的文献求助10
6秒前
Akim的应助被行者采纳,获得10
8秒前
ywd发布了新的文献求助10
9秒前
隐形曼青的应助被学止境采纳,获得50
10秒前
Auoroa完成签到,获得积分10
10秒前
缥缈安荷完成签到,获得积分10
10秒前
LL发布了新的文献求助10
10秒前
YZ发布了新的文献求助10
10秒前
科研通AI6.3的应助被renyun采纳,获得10
11秒前
11秒前
13秒前
13秒前
科研小白完成签到,获得积分10
14秒前
14秒前
syvshc的应助被天真的访文采纳,获得10
15秒前
16秒前
充电宝的应助被chenzhaoyang采纳,获得10
16秒前
16秒前
16秒前
黑米粥发布了新的文献求助200
17秒前
123完成签到,获得积分10
17秒前
ff完成签到 ,获得积分10
17秒前
18秒前
18秒前
ywd完成签到,获得积分10
18秒前
Hello的应助被包容河马采纳,获得10
18秒前
CipherSage的应助被聪明甜桃采纳,获得10
18秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178449
求助须知:如何正确求助?哪些是违规求助? 9569267
关于积分的说明 21803160
捐赠科研通 7773332
什么是DOI,文献DOI怎么找? 3432799
关于科研通互助平台的介绍 2556833
邀请新用户注册赠送积分活动 2478436